Bioventus Inc. Class A Common Stock
BVS US09075A1088
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -25% | -82% | 102% | 100% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Church Katrina J VP |
7.57 USD |
1,283 Sold |
9,712 USD |
11/04/2025 | 11/04/2025 |
| Singleton Mark Leonard VP |
7.57 USD |
3,875 Sold |
29,334 USD |
11/04/2025 | 11/04/2025 |
| D'adamio Anthony VP |
7.57 USD |
2,958 Sold |
22,392 USD |
11/04/2025 | 11/04/2025 |
| Singleton Mark Leonard VP |
9.79 USD |
5,479 Sold |
53,639 USD |
24/03/2025 | 24/03/2025 |
| D'adamio Anthony VP |
9.75 USD |
2,615 Sold |
25,496 USD |
17/03/2025 | 17/03/2025 |
| Church Katrina J VP |
9.75 USD |
1,018 Sold |
9,926 USD |
17/03/2025 | 17/03/2025 |
| Church Katrina J VP |
10.19 USD |
1,537 Sold |
15,662 USD |
18/02/2025 | 18/02/2025 |
| Singleton Mark Leonard VP |
10.19 USD |
6,498 Sold |
66,215 USD |
18/02/2025 | 18/02/2025 |
| D'adamio Anthony VP |
10.19 USD |
4,380 Sold |
44,632 USD |
18/02/2025 | 18/02/2025 |
| Claypoole Robert E CEO |
9.10 USD |
28,786 Sold |
261,953 USD |
13/01/2025 | 13/01/2025 |